Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

K. M. Tewey, G. L. Chen, E. M. Nelson, Leroy-Fong Liu

研究成果: 雜誌貢獻文章

513 引文 斯高帕斯(Scopus)

摘要

Many intercalative antitumor drugs have been shown to induce reversible protein-linked DNA breaks in cultured mammalian cells. Using purified mammalian DNA topoisomerase II, we have demonstrated that the antitumor drugs ellipticine and 2-methyl-9-hydroxyellipticine (2-Me-9-OH-E+) can produce reversible protein-linked DNA breaks in vitro. 2-Me-9-OH-E+ which is more cytotoxic toward L1210 cells and more active against experimental tumors than ellipticine is also more effective in stimulating DNA cleavage in vitro. Similar to the effect of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) on topoisomerase II in vitro, the mechanism of DNA breakage induced by ellipticines is most likely due to the drug stabilization of a cleavable complex formed between topoisomerase II and DNA. Protein denaturant treatment of the cleavable complex results in DNA breakage and covalent linking of one topoisomerase II subunit to each 5'-end of the cleaved DNA. Cleavage sites on pBR322 DNA produced by ellipticine or 2-Me-9-OH-E+ treatment mapped at the same positions. However, many of these cleavage sites are distinctly different from those produced by the antitumor drug m-AMSA which also targets at topoisomerase II. Our results thus suggest that although mammalian DNA topoisomerase II may be a common target of these antitumor drugs, drug-DNA-topoisomerase interactions for different antitumor drugs may be different.

原文英語
頁(從 - 到)9182-9187
頁數6
期刊Journal of Biological Chemistry
259
發行號14
出版狀態已發佈 - 1984
對外發佈Yes

ASJC Scopus subject areas

  • Biochemistry

指紋 深入研究「Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II」主題。共同形成了獨特的指紋。

  • 引用此